Related Experiment Videos

Metabolism of 14C- and 3H-labeled L-ascorbic acid in human scurvy

E M Baker, R E Hodges, J Hood

The American Journal of Clinical Nutrition

|April 1, 1971

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Taladegib for the treatment of idiopathic pulmonary fibrosis (ENV-IPF-101): a multicentre, randomised, double-blind, placebo-controlled, phase 2a trial.

The Lancet. Respiratory medicine·2025

Performance and enteric methane emissions from housed beef cattle fed silage produced on pastures with different forage profiles.

Animal : an international journal of animal bioscience·2023

Modulation of the Wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease-modifying approach for knee osteoarthritis treatment.

Osteoarthritis and cartilage·2019

A small-molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying agent for the treatment of osteoarthritis of the knee.

Osteoarthritis and cartilage·2017

A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study.

Osteoarthritis and cartilage·2017

Impact of a blood management protocol on transfusion rates and outcomes following total hip and knee arthroplasty.

Annals of the Royal College of Surgeons of England·2016

See all related articles